Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
Journal: Circulation. Cardiovascular genetics
Published: February 03, 2015
Potential of proprotein convertase subtilisin/kexin type 9 based therapeutics.
Journal: Current atherosclerosis reports
Published: February 02, 2013
Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.
Journal: The New England journal of medicine
Published: March 23, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026